RP — Replicel Life Sciences Share News
0.000.00%
Last trade - 00:00- CA$0.74m
- CA$1.19m
- CA$0.35m
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector
Brief: Replicel Life Sciences Reports Qtrly Loss Per Share Of C$0.03
Brief: RepliCel Secures New Patents For Its Regenerative Medicine Technologies
Brief: RepliCel Secures Several New Patents For Its Regenerative Medicine Technologies
Brief: RepliCel Announces Federal Grant Funding
Brief: Replicel Life Sciences Appoints New Chief Financial Officer
Brief: RepliCel Life Sciences And Yofoto (China) Health Obtain Approvals Needed To Complete Investment
Development Deal For Greater China
Brief: Replicel Life Sciences Qtrly Basic, Diluted Loss Per Share $0.03
Brief: Replicel Life Sciences Says Has New Binding Term Sheet With China-Based YOFOTO
Brief: RepliCel CEO Provides 2018 Shareholder Update
Brief: RepliCel Life Sciences Lands Commitment For Key Investment Partnership
Brief: Replicel Life Sciences Reports Qtrly Basic And Diluted Loss Per Share $0.06
Brief: RepliCel's partnership initiatives mature into licensing negotiations
Brief: Replicel Life Sciences qtrly loss per share C$0.14
Brief: Replicel Life says signed collaborative research project agreement with University of British Columbia